The ability to rapidly and effectively evaluate the performance of customized next-generation sequencing (NGS) panels is critical to provide high-quality sequencing solutions to customers. New England Biolabs®, together with Directed Genomics®, is developing a new offering, NEBNext Direct® Custom Ready Panels, which will allow researchers to select from a large library of genes for which baits have been developed and optimized, thus enabling rapid deployment of customized target-enrichment panels. Directed Genomics has been collaborating with SeraCare Life Sciences in order to streamline the optimization and characterization of NEBNext Direct target enrichment panels.
Choose your Article Focus | NGS | Molecular & Serology
Cynthia Hendrickson, CEO Directed Genomics
Recent Posts
Reliable Interpretation of NGS Data: New Poster Talk Video
Category: AMP, SeraSeq, NGS, reference materials
Posted by
Cynthia Hendrickson, CEO Directed Genomics on Feb 1, 2018 12:00:00 AM
0 Comments Click here to read/write comments